Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA Approves Obe-cel for ALL
The US Food and Drug Administration (FDA) has approved obecabtagene autoleucel, or obe-cel (AUTO1, Autolus Therapeutics) for the treatment of relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL). Approval of the CD19 chimeric antigen receptor T-cell therapy (CAR T)…
English